Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ATRA Atara Biotherapeutics

Watchlist
5.170
-0.290-5.31%
Close  02/03 16:00 ET
5.1700.0000.00%
Post Mkt Price 02/03 16:02 ET
High
5.380
Open
5.270
Turnover
4.09M
Low
5.165
Pre Close
5.460
Volume
783.07K
Market Cap
490.52M
P/E(TTM)
Loss
52wk High
16.070
Shares
94.88M
P/E(Static)
Loss
52wk Low
2.830
Float Cap
363.30M
Bid/Ask %
-96.08%
Historical High
65.560
Shs Float
70.27M
Volume Ratio
0.91
Historical Low
2.830
Dividend TTM
--
Div Yield TTM
--
P/B
2.62
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.11%
Amplitude
3.94%
Avg Price
5.222
Lot Size
1
Float Cap
363.30M
Bid/Ask %
-96.08%
Historical High
65.560
Shs Float
70.27M
Volume Ratio
0.91
Historical Low
2.830
Dividend TTM
--
P/B
2.62
Dividend LFY
--
Turnover Ratio
1.11%
Amplitude
3.94%
Avg Price
5.222
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.
CEO: Dr. Pascal Touchon
Market: NASDAQ
Listing Date: 10/16/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist